# RAFAEL HOLDINGS, INC. (RFL) · Edgar & Edgarette company card

> Rafael Holdings (RFL) saw revenue fall 4.7% in FY2026 to $1 million, operating margin -3823% against a -3.8% median for pharmaceutical preparations, equity 79.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1713863 · fiscal year ended 2026-07-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/RFL) · [JSON](https://www.pops4.com/boards/company/RFL.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $874,000 |
| Revenue growth, 1 year | -4.7% |
| Revenue growth per year | 20.8% |
| Operating margin | -3822.5% (prior year -3179.8%) |
| Net margin | -3390.7% |
| Operating cash flow | −$30M |
| Capital spending | $3,000 |
| Free cash flow | −$30M |
| Cash | $22M |
| Long-term debt | — |
| Total assets | $83M |
| Total equity | $66M |
| Equity ÷ assets | 79.8% |
| Return on equity | -44.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -5.53 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$30.0M in FY2026); operating loss: a margin of -3822.5% in FY2026; revenue is hard to predict: its 80% range is ±74%

## Edgarette's reading

Exposure: revenue $874K (FY2026). Experience: revenue down 4.7% on the year, up 20.8% a year over 4 years; operating margin -3822.5%, down from -3179.8%. Soundness: equity 79.8% of assets, return on equity -44.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $400K and $2.7M next year (method v4.1: its own 5-year record of growth weighed at 57% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $351K to $3.1M. A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -3822.5% against a -3.8% median; growth -4.7% against 13.7%.

Range logged 2026-11-17, receipt 74645608b81bab32, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- DEF 14A · filed 2026-11-16 · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026120171/0001213900-26-120171-index.htm)
- 8-K · filed 2026-11-09 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026117552/0001213900-26-117552-index.htm)
- 10-K · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026113659/0001213900-26-113659-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026113564/0001213900-26-113564-index.htm)
- 8-K · filed 2026-09-30 · 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026104876/0001213900-26-104876-index.htm)
- 8-K · filed 2026-07-08 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1713863/000121390026076411/0001213900-26-076411-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001713863.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1713863

## Cite

POPS4, Edgar & Edgarette: RAFAEL HOLDINGS, INC. (RFL) company card, from the company's own SEC filings, accessed 2026-11-17, https://www.pops4.com/boards/company/RFL. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

